The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation

Journal of Leukocyte Biology
Emanuela NapoleoneRoberto Lorenzet

Abstract

Pentraxin-3 (PTX3), an acute-phase protein that belongs to the family of the PTXs, is found elevated in septic shock and increased in patients with acute myocardial infarction. As tissue factor (TF) plays a key role in thrombosis and inflammation associated with atherosclerosis and as we have recently reported that PTX3 increases TF synthesis in endothelial cells, we tested whether PTX3 could modulate TF expression in monocytes. Monocytes from peripheral blood of healthy donors were incubated with highly purified PTX3 with or without lipopolysaccharide (LPS). Cells were then disrupted, and procoagulant activity was assessed by a one-stage clotting time. PTX3 enhanced TF activity and antigen from LPS-stimulated monocytes in a dose-dependent way. The effect was specific, as other PTXs, such as C-reactive protein and serum amyloid P component, were ineffective. Moreover, the increase in activity was specific for LPS, as in the presence of other TF-inducing agents such as interleukin-1beta and tumor necrosis factor alpha, PTX3 was not effective. The increase in TF activity requires mRNA synthesis, as assessed by polymerase chain reaction. The mechanism by which PTX3 modulates TF synthesis resides in an enhanced IkappaB, alpha phosp...Continue Reading

References

Mar 1, 1977·The Journal of Clinical Investigation·H RothbergerJ H Vaughan
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·M P BevilacquaM A Gimbrone
Oct 1, 1987·Scandinavian Journal of Gastroenterology·S M AlmdahlB Osterud
Mar 1, 1985·The Journal of Clinical Investigation·E H ColeG A Levy
Jun 1, 1983·The Journal of Clinical Investigation·M ColucciN Semeraro
Feb 1, 1994·The Journal of Experimental Medicine·M A ReadT Collins
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·A CeliB Furie
Aug 18, 1994·The New England Journal of Medicine·G LiuzzoA Maseri
Jan 1, 1995·British Heart Journal·E W LeathamA J Camm
Oct 18, 1996·The Journal of Biological Chemistry·S A SchreyerR C LeBoeuf
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·L HajraM I Cybulsky
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·H HölschermannW Haberbosch
Aug 14, 2001·Journal of the American College of Cardiology·G ValenG K Hansson
May 15, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Michael S RolphGöran K Hansson

❮ Previous
Next ❯

Citations

Nov 13, 2010·Intensive Care Medicine·Bing HanMingyao Liu
Sep 11, 2007·Journal of Clinical Immunology·Alberto MantovaniBarbara Bottazzi
Nov 19, 2008·Clinical Reviews in Allergy & Immunology·N BassiA Doria
Sep 5, 2006·Nature Clinical Practice. Rheumatology·Martine Szyper Kravitz, Yehuda Shoenfeld
Jul 4, 2008·Critical Care Medicine·Tommaso MauriAntonio Pesenti
Jul 25, 2008·Shock·Tom SprongMarcel van Deuren
Mar 18, 2005·Annual Review of Immunology·Cecilia GarlandaAlberto Mantovani
May 12, 2012·Mediators of Inflammation·P KunesJ Krejsek
Jan 24, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Nancy Swords JennyBruce M Psaty
May 29, 2010·Medicine and Science in Sports and Exercise·Asako MiyakiRyuichi Ajisaka
Mar 29, 2014·Experimental and Molecular Pathology·Weishuo LiuQiurong Ruan
Feb 7, 2013·Clinica Chimica Acta; International Journal of Clinical Chemistry·Chao-Wen ChengShun-Fa Yang
Sep 24, 2009·Atherosclerosis·Giuseppe CastellanoGiuseppe Grandaliano
Sep 24, 2011·International Journal of Inflammation·Arthur J Chu
Feb 26, 2013·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Ivana HollanUNKNOWN Feiring Heart Biopsy Study Group
Jan 1, 2013·Heart & Lung : the Journal of Critical Care·Qionghua LinBiao Zhu
Jan 3, 2012·Toxicology Letters·Chang-Dong YeoYoung-Soo Kim
Sep 2, 2011·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Halil YamanKemal M Erbil
Jul 27, 2010·Trends in Cardiovascular Medicine·Giuseppe Danilo NorataAlberico Luigi Catapano
Dec 8, 2009·The Journal of Infection·Martijn D de KruifEric C M van Gorp
Jul 11, 2008·Seminars in Arthritis and Rheumatism·Oscar-Danilo Ortega-HernandezJuan-Manuel Anaya
Feb 20, 2008·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Oliver SeifertAndreas Matussek
Sep 1, 2007·Journal of Cellular and Molecular Medicine·Marco PrestaMarco Rusnati
Jul 8, 2010·The Prostate·Paul F LindholmAndré Kajdacsy-Balla
Apr 15, 2010·Arthritis Care & Research·Ivana HollanUNKNOWN Feiring Heart Biopsy Study Group
Mar 19, 2014·Journal of Thrombosis and Haemostasis : JTH·N S JennyB M Psaty
Oct 7, 2006·Vascular Pharmacology·Alberto MantovaniRoberto Latini
Dec 14, 2005·Current Opinion in Immunology·Barbara BottazziAlberto Mantovani
Mar 17, 2016·Expert Review of Clinical Immunology·Patrick KetterBernard Arulanandam
Dec 17, 2008·Journal of Medical Microbiology·Juergen LoefflerHolger Hebart
May 22, 2013·Mediators of Inflammation·Fabrizia BonacinaGiuseppe Danilo Norata
Jan 25, 2011·Blood Cells, Molecules & Diseases·Erfan NurUNKNOWN CURAMA Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.